Biochemical evidence for structurally distinct H-2Dd antigens differing in serological properties

Area of Science:

• Immunogenetics
• Molecular Immunology
• Major Histocompatibility Complex (MHC) research

Background:

• H-2Dd antigens, defined by the H-2.4 determinant, exhibit heterogeneity.
• The Major Histocompatibility Complex (MHC) D/L end encodes structurally complex antigens.

Purpose of the Study:

• To investigate the immunochemical and structural heterogeneity of H-2Dd antigens.
• To characterize distinct populations of H-2Dd antigens using specific antisera.

Main Methods:

• Utilized anti-H-2.28 serum to distinguish H-2Dd antigen populations.
• Employed sequential precipitation of lentil-lectin-purified glycoproteins.
• Analyzed metabolically labeled splenocytes and cell lines (RADA1).
• Performed paired-label tryptic peptide mapping.

Main Results:

• Identified two immunochemically distinct H-2Dd antigen populations: H-2Dd (b28+) and H-2Dd (b28-).
• Approximately one-third of H-2Dd antigens reacted with anti-H-2.28 (H-2Dd (b28+)), while two-thirds did not (H-2Dd (b28-)).
• Tryptic peptide mapping indicated structural similarity between H-2Dd (b28+) and H-2Dd (b28-), suggesting they are modified forms of the same gene product.

Conclusions:

• H-2Dd antigens exist as at least two distinct populations with complex serological and structural relationships.
• The observed differences likely represent modifications of a single gene product rather than distinct genetic loci.
• Further research is needed to clarify quantitative differences and their origins.